Cellular Immunity of Patients with Tuberculosis Combined with Diabetes.
Journal
Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
03
2022
accepted:
19
05
2022
entrez:
13
6
2022
pubmed:
14
6
2022
medline:
15
6
2022
Statut:
epublish
Résumé
Tuberculosis (TB) is one of humanity's three major infectious diseases. Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia due to impaired insulin secretion or impaired insulin function. It has been reported that DM is a primary risk factor for TB disease. Given the increasing public health threat to people's health, more and more studies have focused on diabetes complicated by TB. Hyperglycemia can affect the function of human immune cells, promote primary infections and reactivation of TB, and increase the susceptibility and severity of TB. However, the immunological mechanism behind it is still not clear. By reviewing the related articles on tuberculosis complicated with diabetes published in recent years, this paper expounds on the effect of hyperglycemia on innate immunity and adaptive immunity of patients with TB. This review provides new insights for elucidating the immunological mechanism of TB complicated with DM and lays the foundation for finding potential targets for preventing and treating TB combined with DM.
Identifiants
pubmed: 35692502
doi: 10.1155/2022/6837745
pmc: PMC9177301
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
6837745Informations de copyright
Copyright © 2022 Peng Cheng et al.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Tuberculosis (Edinb). 2003;83(1-3):98-106
pubmed: 12758197
Tuberculosis (Edinb). 2016 Dec;101:191-200
pubmed: 27865391
Cytokine. 2016 May;81:127-36
pubmed: 27002606
PLoS One. 2017 May 30;12(5):e0178000
pubmed: 28558065
Nat Immunol. 2016 Jan;17(1):34-40
pubmed: 26681460
Immunology. 2019 Mar;156(3):249-258
pubmed: 30427060
J Infect Dis. 2016 Dec 1;214(11):1629-1637
pubmed: 27630197
J Exp Med. 2006 Jul 10;203(7):1805-15
pubmed: 16818672
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
J Biol Chem. 2018 Oct 19;293(42):16160-16173
pubmed: 30213857
Microbes Infect. 2020 Apr;22(3):111-118
pubmed: 31689532
J Fungi (Basel). 2017 May 19;3(2):
pubmed: 29371543
JCI Insight. 2020 Mar 12;5(5):
pubmed: 32161191
Semin Immunopathol. 2015 May;37(3):239-49
pubmed: 25917388
Biochem Biophys Rep. 2021 Apr 22;26:100997
pubmed: 33997314
Cell Mol Immunol. 2017 Dec;14(12):963-975
pubmed: 28890547
PLoS Pathog. 2014 May 15;10(5):e1004099
pubmed: 24831696
Clin Chim Acta. 2020 Nov;510:566-572
pubmed: 32818492
Microb Pathog. 2021 Sep;158:105068
pubmed: 34245822
Front Microbiol. 2021 Oct 22;12:745592
pubmed: 34745048
J Diabetes Res. 2016;2016:6014631
pubmed: 27057552
Chest. 2017 Jul;152(1):174-180
pubmed: 28434937
Front Immunol. 2022 Jan 31;13:830497
pubmed: 35173740
J Leukoc Biol. 2019 Aug;106(2):275-282
pubmed: 30938876
J Exp Med. 1992 Jan 1;175(1):49-56
pubmed: 1530961
Front Immunol. 2020 Jul 22;11:1582
pubmed: 32793223
Front Cell Infect Microbiol. 2021 Oct 26;11:756854
pubmed: 34765568
Immunology. 2016 Sep;149(1):87-97
pubmed: 27289086
Front Immunol. 2021 Nov 26;12:712021
pubmed: 34899683
Immunology. 2015 Apr;144(4):677-86
pubmed: 25363329
Biomed Res Int. 2020 May 19;2020:8085106
pubmed: 32509871
Tuberculosis (Edinb). 2017 Jan;102:47-54
pubmed: 28061952
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
J Glob Health. 2021 Jul 24;11:04040
pubmed: 34386215
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Immun Inflamm Dis. 2018 Jun;6(2):345-353
pubmed: 29642283
Trends Immunol. 2012 Jan;33(1):14-25
pubmed: 22094048
J Epidemiol Community Health. 2012 Jun;66(6):519-23
pubmed: 21109542
Immunology. 2017 Sep;152(1):13-24
pubmed: 28543817
World J Diabetes. 2016 Jul 10;7(13):271-8
pubmed: 27433296
Sci Rep. 2019 Dec 10;9(1):18669
pubmed: 31822686
Mem Inst Oswaldo Cruz. 2018 Feb 19;113(4):e170326
pubmed: 29513874
Med Sci Monit. 2018 Jan 31;24:636-642
pubmed: 29385117
Front Cell Infect Microbiol. 2021 Jul 06;11:691823
pubmed: 34295838
Endocrinol Metab Clin North Am. 2021 Sep;50(3):337-355
pubmed: 34399949
PLoS Pathog. 2019 Dec 6;15(12):e1008140
pubmed: 31809521
Lung. 2019 Feb;197(1):89-94
pubmed: 30474709
Exp Clin Endocrinol Diabetes. 2008 Mar;116(3):162-6
pubmed: 18213547
Eur J Immunol. 2002 Jun;32(6):1605-13
pubmed: 12115643
Nat Med. 1999 Aug;5(8):919-23
pubmed: 10426316
Immunol Lett. 2017 Jun;186:41-45
pubmed: 28377108
Annu Rev Immunol. 1989;7:145-73
pubmed: 2523712
J Diabetes Complications. 2018 Sep;32(9):857-862
pubmed: 30025786
Front Immunol. 2021 Apr 26;12:666290
pubmed: 33981313
PLoS Pathog. 2016 Oct 26;12(10):e1005972
pubmed: 27783671
Pneumologie. 2018 Jul;72(7):493-502
pubmed: 29270952
Immunol Cell Biol. 2021 Nov;99(10):1026-1039
pubmed: 34379824
J Infect Dis. 2016 Mar 1;213(5):866-70
pubmed: 26486635
BMC Med. 2011 Jul 01;9:81
pubmed: 21722362
BMC Infect Dis. 2021 May 20;21(1):461
pubmed: 34016046
Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1259-1263
pubmed: 29679254
J Infect Dis. 2013 Sep 1;208(5):739-48
pubmed: 23715661